Sales in the period were over £320 million (2007: £263 million), up 22% on the same period last year.  This increase reflects growth in our two global brands, Durex and Scholl, and our strong positioning within the Euro zone.  After adjusting for favourable currency movements underlying sales have increased by over 9%.

Durex’s performance has been driven in particular by the branded condoms range in the U.K., Eastern Europe, Russia and China; and by the Play range in Italy and France. Scholl footcare sales growth has been led by the roll-out of Perfect Nail and continued strong performance of Cracked Heel Repair Cream especially in the U.K., Italy and France. Scholl footwear sales in Italy, France and Thailand have also delivered good growth.

Garry Watts, Chief Executive, commented: “We've had a very good first half with investment in new products and regional expansion paying off.  Whilst the consumer environment is and will continue to be challenging, our strong balance sheet and our international spread means we can have confidence in attaining our target of double digit operating profit growth again this financial year.”

-         End  - 

For further information, please contact: